Isotretinoin for the Treatment of Facial Lichen Planopilaris: A New Indication for an Old Drug, a Case Series Study

Isotretinoin for the Treatment of Facial Lichen Planopilaris: A New Indication for an Old Drug, a Case Series Study Publisher

Fatemi F¹ ; Mohaghegh F¹ ; Danesh F¹ ; Saber M¹ ; Rajabi P²

Show Affiliations

1. Department of Dermatology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
2. Pathology Department, Faculty of Medicine, Isfahan university of Medical Sciences, Isfahan, Iran

Source: Clinical Case Reports Published:2020

Abstract

Despite the little information about the facial papules due to Lichen planopilaris (LPP), we have many cases with facial skin roughness in which histological study has showed LPP. Additionally, in those patients treating for frontal fibrosing alopecia or scalp LPP there was no improvement in facial papules. © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd

Related Docs

View other Related Docs

1. Comparison of Systemic and Topical Isotretinoin in the Treatment of Facial Lichen Planopilaris: A Randomized Controlled Trial, Journal of Cosmetic Dermatology (2022)

2. The Simultaneous Occurrence of Lichen Planopilaris and Alopecia Areata: A Report of Two Cases and Literature Review, Clinical Case Reports (2020)

3. Comparative Efficacy Study Combination of Oral Methotrexate and Prednisolone Versus Oral Methotrexate in Patients With Lichen Planopilaris, Dermatology Research and Practice (2022)

4. Cyclosporine or Methotrexate, Which One Is More Promising in the Treatment of Lichen Planopilaris?; a Comparative Clinical Trial, International Immunopharmacology (2020)

5. Clinical Effectiveness of Finasteride Versus Hydroxychloroquine in the Treatment of Frontal Fibrosing Alopecia: A Randomized Controlled Trial, Journal of Cosmetic Dermatology (2024)

6. Clinical Efficacy and Safety of Methotrexate Versus Hydroxychloroquine in Preventing Lichen Planopilaris Progress: A Randomized Clinical Trial, International Journal of Preventive Medicine (2017)

7. Comparison of the Narrow Band Uvb Versus Systemic Corticosteroids in the Treatment of Lichen Planus: A Randomized Clinical Trial, Journal of Research in Medical Sciences (2011)

8. Coexistence of Periorbital Lichen Planus Pigmentosus and Pemphigus Vulgaris: Report of an Unusual Case and a Rare Association, Clinical Case Reports (2021)

Experts (# of related papers)

View all Related Experts

Fatemeh Mohaghegh (6)

Mina Saber (6)

Style	Citing Format
MLA	Fatemi F, et al.. "Isotretinoin for the Treatment of Facial Lichen Planopilaris: A New Indication for an Old Drug, a Case Series Study." Clinical Case Reports, vol. 8, no. 12, 2020, pp. 2524-2529.
APA	Fatemi F, Mohaghegh F, Danesh F, Saber M, Rajabi P (2020). Isotretinoin for the Treatment of Facial Lichen Planopilaris: A New Indication for an Old Drug, a Case Series Study. Clinical Case Reports, 8(12), 2524-2529.
Chicago	Fatemi F, Mohaghegh F, Danesh F, Saber M, Rajabi P. "Isotretinoin for the Treatment of Facial Lichen Planopilaris: A New Indication for an Old Drug, a Case Series Study." Clinical Case Reports 8, no. 12 (2020): 2524-2529.
Harvard	Fatemi F et al. (2020) 'Isotretinoin for the Treatment of Facial Lichen Planopilaris: A New Indication for an Old Drug, a Case Series Study', Clinical Case Reports, 8(12), pp. 2524-2529.
Vancouver	Fatemi F, Mohaghegh F, Danesh F, Saber M, Rajabi P. Isotretinoin for the Treatment of Facial Lichen Planopilaris: A New Indication for an Old Drug, a Case Series Study. Clinical Case Reports. 2020;8(12):2524-2529.
BibTex	@article{ author = {Fatemi F and Mohaghegh F and Danesh F and Saber M and Rajabi P}, title = {Isotretinoin for the Treatment of Facial Lichen Planopilaris: A New Indication for an Old Drug, a Case Series Study}, journal = {Clinical Case Reports}, volume = {8}, number = {12}, pages = {2524-2529}, year = {2020} }
RIS	TY - JOUR AU - Fatemi F AU - Mohaghegh F AU - Danesh F AU - Saber M AU - Rajabi P TI - Isotretinoin for the Treatment of Facial Lichen Planopilaris: A New Indication for an Old Drug, a Case Series Study JO - Clinical Case Reports VL - 8 IS - 12 SP - 2524 EP - 2529 PY - 2020 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract